Pharmaceutical software company Veeva Systems has sued Microsoft in California federal court, alleging Microsoft's Viva ...
Leading biopharma to unify global regulatory operations on a single platform to speed submissions for new patient therapies BARCELONA, Spain, Feb. 4, 2025 /PRNewswire/ -- Veeva Systems ...
BARCELONA, Spain, Feb. 4, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Servier will adopt Veeva RIM to unify its global regulatory operations. By bringing regulatory processes ...
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good ...
Veeva Systems (VEEV) closed the most recent trading day at $233.29, moving +0.01% from the previous trading session.
Hantz Financial Services Inc. lessened its holdings in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 64.8% during the 4th ...
Blue Trust Inc. lifted its holdings in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 28.0% in the fourth quarter, ...
Buying $1000 In VEEV: If an investor had bought $1000 of VEEV stock 10 years ago, it would be worth $7,775.33 today based on a price of $233.26 for VEEV at the time of writing.
Biopharmas use leading CTMS for improved trial efficiency and collaboration BARCELONA, Spain, Jan. 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 200 ...
Veeva Systems defies RTO trends, offering flexible, high-paying remote jobs. Discover why their "Work Anywhere" policy is ...
Veeva Systems Inc. VEEV is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by a solid third-quarter fiscal 2025 performance and strategic ...
Veeva Systems' specialization in life sciences, strong balance sheet, and innovative culture position it well for long-term ...